- Home
- LIQT vs KZIA Comparison
LIQT vs KZIA Comparison
Compare LIQT & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LIQT | KZIA |
|---|---|---|
| Founded | 2004 | 1994 |
| Country | Denmark | Australia |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.7M | 93.2M |
| IPO Year | 2011 | 2002 |
Fundamental Metrics
Financial Performance| Metric | LIQT | KZIA |
|---|---|---|
| Price | $1.58 | $7.98 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $4.30 | ★ $17.67 |
| AVG Volume (30 Days) | 9.8K | ★ 183.8K |
| Earning Date | 02-27-2026 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $35.32 | N/A |
| Revenue Next Year | $71.69 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.34 | $0.64 |
| 52 Week High | $3.35 | $17.40 |
Technical Indicators
Market Signals| Indicator | LIQT | KZIA |
|---|---|---|
| Relative Strength Index (RSI) | 51.09 | 49.96 |
| Support Level | $1.43 | $7.54 |
| Resistance Level | $2.00 | $8.17 |
| Average True Range (ATR) | 0.17 | 1.08 |
| MACD | 0.01 | -0.13 |
| Stochastic Oscillator | 37.68 | 17.09 |
Price Performance
Historical ComparisonAbout LIQT LiqTech International Inc.
LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in businesses that are liquid filtration market and the silicon carbide ceramic membrane & diesel particulate filter (DPF) market. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and others. Its operating segment includes Water, Ceramics, and Plastics.
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.